BATTAGLIA, GLORIANA
 Distribuzione geografica
Continente #
NA - Nord America 1.507
EU - Europa 776
AS - Asia 667
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.958
Nazione #
US - Stati Uniti d'America 1.488
CN - Cina 479
SE - Svezia 329
IE - Irlanda 321
TR - Turchia 152
FI - Finlandia 30
SG - Singapore 22
CA - Canada 18
DE - Germania 16
UA - Ucraina 16
AT - Austria 15
BE - Belgio 8
FR - Francia 8
IT - Italia 7
NL - Olanda 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
GB - Regno Unito 3
HR - Croazia 3
IN - India 3
IR - Iran 3
EU - Europa 2
HK - Hong Kong 2
JP - Giappone 2
LU - Lussemburgo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
TG - Togo 1
Totale 2.958
Città #
Chandler 524
Dublin 321
Dearborn 130
Izmir 126
Nanjing 111
Ashburn 99
Beijing 94
Princeton 70
New York 52
Wilmington 41
Hebei 30
Helsinki 30
Nanchang 29
Shanghai 28
Kocaeli 26
Shenyang 26
Changsha 19
Kunming 19
Tianjin 18
Jiaxing 17
Toronto 16
Seattle 15
Vienna 15
Hangzhou 14
Hefei 13
Jacksonville 12
Jinan 12
San Mateo 12
Fremont 10
Norwalk 10
Brussels 8
Zhengzhou 8
Guangzhou 7
Ann Arbor 6
Borås 4
Lanzhou 4
Leawood 4
Singapore 4
Washington 4
Cambridge 3
Edinburgh 3
Haikou 3
Ningbo 3
Pune 3
Shaoxing 3
Sofia 3
Wuhan 3
Xian 3
Zagreb 3
Bratislava 2
Bremen 2
Chicago 2
Eindhoven 2
Falls Church 2
Luxembourg 2
Paris 2
Parma 2
Pulsano 2
Stockholm 2
Taizhou 2
Tokyo 2
Wanchai 2
Zanjan 2
Andover 1
Augusta 1
Baotou 1
Belgrade 1
Berlin 1
Boardman 1
Bridgewater 1
Changchun 1
Chengdu 1
Chisinau 1
Chongqing 1
Dambulla 1
Easley 1
Fayetteville 1
Ferentino 1
Frankfurt am Main 1
Fuzhou 1
Geislingen an der Steige 1
Grandview 1
Harbin 1
Houston 1
Los Angeles 1
Macao 1
Madrid 1
Manila 1
Miami 1
Milan 1
Nuremberg 1
Panama City 1
Prague 1
Rockville 1
Rome 1
Santa Clara 1
Tallinn 1
Tel Aviv 1
Timisoara 1
Vargem Grande 1
Totale 2.083
Nome #
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 70
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 64
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 61
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 60
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 58
Milk consumption and duodenal ulcer outcome: A short- and long-term study 58
H2antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine 57
Studio scintigrafico del tempo di svuotamento gastrico in pazienti con ulcera duodenale 57
The natural history of duodenal ulcer disease 56
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 56
Fasting and post-prandial serum gastrin concentrations in peptic ulcer disease. Pathophysiological considerations in relationship to the different localization 56
H2-blockers in the treatment of ulcer disease in the elderly 56
Personality traits and gastric acid secretion in ulcer disease 56
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 55
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 55
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 54
Long-term treatment for gastric and duodenal ulcer 54
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 54
Individualized treatment of duodenal ulcer disease. A pilot study 54
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 52
Azithromycin for the cure of Helicobacter pylori infection 51
Clinical markers of slow healing and relapsing gastric ulcer 51
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 50
Gastric and duodenal ulcer in the same patient 49
Ulcera gastrica, ulcera duodenale e gruppi sanguigni "maggiori e minori". Aspetti epidemiologici, correlazioni funzionali, implicazioni cliniche 48
Compliance with therapy for ulcer disease: clinical experience and review of the literature 48
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 48
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 48
LA BULBODUODENITE NON ULCEROSA: ASPETTI CLINICI E TRATTAMENTO FARMACOLOGICO 47
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 46
A preliminary report on Helicobacter pylori and antral gastrin concentration in patients with duodenal ulcer 46
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 45
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 44
Risk factors of duodenal ulcer bleeding: the role of smoking and nicotine 43
Mucosal pepsin and group I pepsinogen concentration in peptic ulcer patients with a history of bleeding 43
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 42
Blood pepsinogen as a subclinical marker for duodenal ulcer 41
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 41
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 40
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 40
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 39
A therapeutic strategy after a first ineffective cure of H. pylori infection. One-centre experience on 74 consecutive patients 38
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 37
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 37
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 36
A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study 36
Cefixime for the eradication of helicobacter pylori 36
Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication 35
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules 35
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia 35
EFFETTO DELLA NIZATIDINA E DEL MISOPROSTOL SULL'ATTIVITA PEPTICA E SUL MUCO GASTRICO SOLUTO 35
Helicobacter pylori eradication: Can a successful therapy be predicted? 35
Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study on 286 subjects 35
Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori 34
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series 34
Gastric ulcer and stomach aging: Pathophysiology and clinical implications 34
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 34
Sucralfate for preventing gastric ulcer relapse: A controlled prospective study 34
Lymphoid follicles in gastric mucosa of Helicobacter pylori infected patients regress after eradication treatment 33
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 33
Valutazione clinica della gastrinemia basale nella malattia ulcerosa 32
Helicobacter pylori and Serum Pepsinogen A, Pepsinogen C, and Gastrin: A Methodological Note 31
Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study 31
High IgE serum levels and "peptic" ulcers: clinical and functional approach 29
One year follow-up of malt lymphoma of the stomach: Evidence for the need of an accurate diagnostic management 28
ULCERA PEPTICA E CIRROSI EPATICA. CONSIDERAZIONI CLINICO-EPIDEMIOLOGISCHE 28
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs 27
Seasonal Fluctuations in Peptic Ulcer Bleeding: An Italian Experience 24
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 23
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 22
Totale 3.034
Categoria #
all - tutte 10.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019179 0 0 0 0 0 0 0 0 0 5 144 30
2019/2020579 201 94 11 1 30 106 39 12 19 49 16 1
2020/202181 1 6 6 0 1 0 5 1 15 29 10 7
2021/2022269 0 0 1 17 14 2 3 25 18 15 28 146
2022/20231.461 133 149 131 132 95 184 7 122 415 6 71 16
2023/2024316 13 49 11 9 31 127 7 34 17 18 0 0
Totale 3.034